LABRHA INTERNATIONAL
  • ABOUT US
  • NEW VISCOSUPPLEMENTS
    • HAPPYVISC®
    • HAPPYCROSS®
    • HAPPYMINI®
  • FOOD SUPPLEMENTS
    • Fibromyalgia
    • Joint and bone health
    • Natural anti-inflammatory
    • Tendon health
  • TOPICAL GELS
    • CAPSAÏNE GEL
    • CICATENDON gel
  • CLINICAL DATA
    • PUBLICATIONS
    • EUROPEAN BOARD ON VISCOSUPPLEMENTATION
    • EVENTS & NEWS
  • BECOME A PARTNER

Labrha International now registred in EUROPAGES.

Published by admin on 17/04/202317/04/2023

Labrha International is now registred in Europages, the largest B2B sourcing platform.
Our objective is to be more accessible to potential distributors and business partners around the world.

Discover our page on europages and do not hesitate to contact us!

 

Categories: EVENTS & NEWS

LABRHA ONLINE SHOP

www.laboratoire-labrha.fr

LABRHA – FRANCE

www. labratoire-labrha.fr

BECOME A DISTRIBUTOR

Join our Distributor Network

ASK QUESTIONS

Related Posts

Eurovisco members
EUROPEAN BOARD ON VISCOSUPPLEMENTATION

7th Edition of the European Board on Viscosupplementation

As every year since 2014, with the exception of 2020 due to the Covid pendemia, the EUROVISCO group met in Lyon on September 7 and 8, 2022 for its annual meeting. The subject of the Read more…

CLINICAL STUDIES

LABRHA at the SFR Congress in Paris in December 2017

LABRHA took part in the 30th annual Congress of the French Society of Rheumatology (SFR) which took place last 10th to 12th of December in Paris. During this congress LABRHA presented its latest scientific works Read more…

CLINICAL STUDIES

LABRHA at the ISIAT Congress in Prague in October 2017

The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), Read more…


  • ABOUT US
  • BECOME A PARTNER
  • Blog
  • CLINICAL STUDIES
  • FOOD SUPPLEMENTS
  • Front Page
  • NEW VISCOSUPPLEMENTS
  • TOPICAL GELS
Hestia | Developed by ThemeIsle